In 2023, during Bidens Presidency, the Food and Drug Administration placed nineteen peptides, including BPC-157, on a do not compound list, citing potential significant safety risks that included immune reactions, pancreatitis, and accelerated growth of cancerous cells
We might find it strange to find a revolutionary peptide in our stomachs, but BPC-157 therapy has had remarkable results
Therapeutic Potential of Quercetin as an Antiatherosclerotic Agent in Atherosclerotic Cardiovascular Disease: A Review. Evidence-based Complementary and Alternative Medicine: eCAM, 2020
PLoS ONE 10 , e0123454
Clinically proven in dogs: significant improvement was shown when administered twice daily compared to the standard lubrication product on the market 1 Long-lasting lubrication: ordinary eye drops can quickly evaporate Engineered for convenience: enhanced duration reduces the number of applications Tailored for easy application: specifically made to create a not too thick, not too watery consistency that is easy to control and dispense accurately Less glob on your pets eyes: unlike others, Ocunovis creates a sheer thin application without blurring Formulation based on naturally occurring substances found in the body contains no preservative or synthetic additives that cause pain or stinging The only eye drops with proven BioHAnce technology
IV glutathione delivers nutrients directly to the bloodstream for faster and more visible results